August 01, 2012

Multidrug approach fights resistance

Research results suggest that of the billions of cancer cells that exist in a patient, only about one in a million is resistant to drugs using targeted therapy.

News about pertuzumab injection (Perjeta); ondansetron (Zofran); carfilzomib (Kyprolis); Therascreen KRAS RGQ PCR Kit; Prostate Health Index (phi); and Prepopik

September: A month for cancer awareness

Patient information on coping with the emotional toll of cancer, making treatment decisions, dietary and nutritional needs, and survivorship care